Merck & Co., Inc.
corporate_fare Company Profile
Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek monitors MRK SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Merck Clears Key Antitrust Hurdle for Terns Pharmaceuticals Acquisition
- US FDA Approves Merck's New Combination HIV Treatment
- Merck-Eisai Cancer Therapy Fails Late-Stage Study Goals
- FDA Grants Priority Review to Merck, Pfizer Bladder Cancer Drug Combo
- Merck Actively Pursues Acquisitions to Bolster Pipeline Ahead of Keytruda Patent Expiration
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063
show_chartPrice Chart
Loading chart...
feed MRK - Filings & News (Page 2)
MRK
Apr 24, 2026, 6:45 AM EDT
Price at Filing:
$113.99
Real-time Price:
$127.51
Change:
+$13.52 (+12%)
Market Cap:
$314.903B
MRK
Apr 21, 2026, 11:50 AM EDT
Price at Filing:
$112.55
Real-time Price:
$127.51
Change:
+$14.96 (+13%)
Market Cap:
$314.903B
MRK
Apr 21, 2026, 6:51 AM EDT
Price at Filing:
$116.99
Real-time Price:
$127.51
Change:
+$10.52 (+9%)
Market Cap:
$314.903B
MRK
Apr 20, 2026, 7:29 AM EDT
Price at Filing:
$118.52
Real-time Price:
$127.51
Change:
+$8.99 (+8%)
Market Cap:
$314.903B
MRK
Apr 13, 2026, 4:06 PM EDT
Price at Filing:
$119.66
Real-time Price:
$127.51
Change:
+$7.85 (+7%)
Market Cap:
$314.903B
MRK
Apr 08, 2026, 4:25 PM EDT
Price at Filing:
$123.49
Real-time Price:
$127.51
Change:
+$4.02 (+3%)
Market Cap:
$314.903B
MRK
Mar 30, 2026, 4:04 PM EDT
Price at Filing:
$118.10
Real-time Price:
$127.51
Change:
+$9.41 (+8%)
Market Cap:
$314.903B
MRK
Mar 30, 2026, 11:48 AM EDT
Merck's Oral PCSK9 Inhibitor Enlicitide Decanoate Slashes LDL-C by 64.6%, Earns FDA Priority Voucher
Price at Filing:
$118.06
Real-time Price:
$127.51
Change:
+$9.45 (+8%)
Market Cap:
$314.903B
MRK
Mar 29, 2026, 11:49 AM EDT
Price at Filing:
$119.27
Real-time Price:
$127.51
Change:
+$8.24 (+7%)
Market Cap:
$314.903B
MRK
Mar 25, 2026, 6:45 AM EDT
Price at Filing:
$116.68
Real-time Price:
$127.51
Change:
+$10.83 (+9%)
Market Cap:
$314.903B
MRK
Mar 24, 2026, 9:03 PM EDT
Price at Filing:
$116.68
Real-time Price:
$127.51
Change:
+$10.83 (+9%)
Market Cap:
$314.903B
MRK
Mar 05, 2026, 3:04 PM EST
Price at Filing:
$115.78
Real-time Price:
$127.51
Change:
+$11.73 (+10%)
Market Cap:
$314.903B
MRK
Feb 28, 2026, 10:08 AM EST
Price at Filing:
$123.31
Real-time Price:
$127.51
Change:
+$4.20 (+3%)
Market Cap:
$314.903B
MRK
Feb 28, 2026, 10:03 AM EST
Price at Filing:
$123.31
Real-time Price:
$127.51
Change:
+$4.20 (+3%)
Market Cap:
$314.903B
MRK
Feb 27, 2026, 10:28 AM EST
Price at Filing:
$121.49
Real-time Price:
$127.51
Change:
+$6.03 (+5%)
Market Cap:
$314.903B
MRK
Feb 27, 2026, 10:24 AM EST
Price at Filing:
$121.41
Real-time Price:
$127.51
Change:
+$6.10 (+5%)
Market Cap:
$314.903B
MRK
Feb 24, 2026, 4:15 PM EST
Price at Filing:
$124.00
Real-time Price:
$127.51
Change:
+$3.51 (+3%)
Market Cap:
$314.903B
MRK
Feb 03, 2026, 6:38 AM EST
Price at Filing:
$112.00
Real-time Price:
$127.51
Change:
+$15.51 (+14%)
Market Cap:
$314.903B